FDA
-
-
-
-
-
-
-
Insulet Initiates Voluntary Medical Device Correction for Certain Omnipod® Pods in the U.S. and Affected International Markets
-
-
-
-
-
-
-
Insulet Presents Promising Study Results for Fully Closed-Loop Automated Insulin Delivery System for Adults with Type 2 Diabetes
-
-
-
-
-
-
-
Insulet Reports Third Quarter 2025 Results
-
-
-
-
-
-
-
Insulet Appoints Ashley McEvoy President and CEO
-
-
-
-
-
-
-
Omnipod® 5 App for iPhone® Now Fully Available in the United States
-
-
-
-
-
-
-
Insulet Reports Preliminary Second Quarter 2024 Revenue Results
-
-
-
-
-
-
-
Insulet Announces FDA 510(k) Clearance of the Omnipod® 5 App for iPhone
-
322,953 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

